NewcelX Stock (NASDAQ:NCEL)
Previous Close
$3.34
52W Range
$1.83 - $28.03
50D Avg
$3.58
200D Avg
$3.52
Market Cap
$1.49M
Avg Vol (3M)
$36.41K
Beta
0.93
Div Yield
-
NCEL Company Profile
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.